Market
Synopsis of U.S. Personalized Medicine Market:
Market
Scenario:
The
Personalized Medicine Market is the most recent trend in the
multibillion–dollar molecular diagnostics industry. Pharmaceutical and
biotechnology companies are increasingly turning to personalized medicine in
order to improve the drug development process and also to speed up the approval
or sanction of new drugs.
According
to the industry consensus, personalized medicine will not only form an integral
part of typical medicine in the next few years, it is also anticipated to
reform the development, testing, marketing and prescription of drugs during the
next decade. The big pharmaceutical companies eventually will change their
tried and tested epic business model to more–targeted and effective healthcare
solutions. U.S personalized medicine market is expected to grow at the CAGR of
7.5% during the forecasted period.
Key
players of U.S. Personalized Medicine Market:
Key
players profiled in the report are Laboratory Corporation of America, Quest
Diagnostics, Abbott, Becton Dickinson & Co., Siemens Healthcare Diagnostics
Inc., GE Healthcare, Pfizer Inc., Sanofi, CardioDx Inc., Asuragen Inc. and
Bristol-Myers Squibb.
Get Sample Copy @
Segments:
The U.S.
Personalized Medicine Market is segmented on the basis of product, application
and end users. Based on the product, the market has been segmented as diagnostic, therapeutics, medical
care and nutrition and wellness and
others. Based on application, the market has been segmented into diagnosis and
intervention, drug development and usage, cancer genomics and others. Further on the basis of end users
the market has been segmented as hospitals, molecular diagnostic laboratories and
testing centers, academic institutes, bio and health informatics companies and
others.
Detailed Table
of Contents:
Table Of Contents
1 Introduction
1.1
Definition
1.2
Scope Of Study
1.2.1
Research Objective
1.2.2 Assumptions
& Limitations
1.2.2.1
Assumptions
1.2.2.2
Limitations
1.3
Market Structure:
2 Research Methodology
2.1
Research Process:
2.2
Primary Research
2.3
Secondary Research:
3 Market Dynamics
3.1
Drivers
3.2
Restraints
3.3
Opportunities
3.4
Macroeconomic Indicators
4 Market Factor Analysis
4.1
Porters Five Forces Model
4.2
Bargaining Power Of Suppliers
4.3
Bargaining Power Of Buyers
4.4
Threat Of New Entrants
4.5
Threat Of Substitutes
4.6
Intensity Of Rivalry
5 U.S. Personalised Medicine Market, By Product
5.1
Diagnostic
5.2
Therapeutics
5.3
Medical Care
5.4
Nutrition And Wellness
5.5
Others
...Continued
Regional
analysis
U.S.
accounts for the maximum market share of the personalized medicine market and
the market is expected to increase continuously in coming years. This can be
attributed to increasing pool of cancer patients along with high healthcare per
capita expenditure. Advancing technologies within the liquid biopsy or cancer
market is also driving the market and will see strategic growth over the next
five years. The two segments of the liquid biopsy market are tumor cell
enrichment products and tumor cell detection technologies which are expected to
command the maximum market share.
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment